|
Re: Clarification on BETonMACE baseline data
|
3
|
Resverlogix Corp.
|
Sep 05, 2019 02:34AM
|
|
Re: CKD Reata / Market Cap
|
4
|
Resverlogix Corp.
|
May 03, 2019 10:31AM
|
|
Re: CKD or CD,... or both
|
4
|
Resverlogix Corp.
|
Oct 08, 2019 02:34AM
|
|
Re: CKD & VCD clarification
|
2
|
Resverlogix Corp.
|
Jun 03, 2019 12:49PM
|
|
Re: citi LoC
|
3
|
Resverlogix Corp.
|
Feb 05, 2017 02:14PM
|
|
Re: citi LoC
|
2
|
Resverlogix Corp.
|
Feb 05, 2017 04:35PM
|
|
Re: CIBC hellbent on torpedoing RVX
|
2
|
Resverlogix Corp.
|
Jun 16, 2017 02:40AM
|
|
Re: Chinese Takeovers
|
3
|
Zenith Epigenetics
|
Mar 08, 2018 03:59AM
|
|
Re: Chinese Takeovers
|
2
|
Zenith Epigenetics
|
Mar 08, 2018 12:54PM
|
|
Re: Chinese Takeovers
|
4
|
Zenith Epigenetics
|
Mar 07, 2018 12:56PM
|
|
Re: Chemical probes targeting epigenetic proteins: Applications beyond oncology
|
2
|
Resverlogix Corp.
|
Aug 05, 2017 02:25AM
|
|
Re: Chemical probes targeting epigenetic proteins: Applications beyond oncology
|
6
|
Resverlogix Corp.
|
Aug 05, 2017 01:46PM
|
|
Re: Cheeseburgers and Pork Ribs
|
2
|
Resverlogix Corp.
|
Mar 09, 2017 08:15PM
|
|
Re: Checking the chart and seeing another pennant, contractions coming quicker....
|
5
|
Resverlogix Corp.
|
May 12, 2019 12:13PM
|
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
6
|
Zenith Epigenetics
|
Feb 03, 2019 04:01AM
|
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
3
|
Zenith Epigenetics
|
Jan 30, 2019 10:04AM
|
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
2
|
Zenith Epigenetics
|
Feb 11, 2019 10:41PM
|
|
Re: Cayman Chemical 1180 East Ellsworth Road Ann Arbor, Michigan 48108 USA
|
|
Resverlogix Corp.
|
Jan 16, 2017 09:48AM
|
|
Re: Caution
|
4
|
Resverlogix Corp.
|
Nov 14, 2019 06:00PM
|
|
Re: Caution
|
2
|
Resverlogix Corp.
|
Nov 14, 2019 06:23PM
|
